je.st
news
Gilead's Sovaldi Awarded Breakthrough Designation
2014-01-05 20:08:18| Biotech - Topix.net
A number of drugs currently in development were approved for a "breakthrough therapy" designation from the Food and Drug Administration this past year, with Gilead Sciences' Sovaldi, a medicine used to treat hepatitis C, leading the group, reports Bloomberg .
Tags: awarded
designation
breakthrough
designation awarded
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|